Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Êàðäèîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé êàðäèîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #31  
Ñòàðûé 09.10.2007, 17:17
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò ostroumov Ïîñìîòðåòü ñîîáùåíèå
Ñöèíòèãðàôèÿ ñ 201-ÒË íå ïîäñêàæåò ïîäâèæåí ëè ìèîêàðä â çîíå ñíèæåíèÿ ïåðôóçèè. È âîîáùå, ãäå îí ïîäâèæåí?
Ïî÷åìó. Åe æå òîæå ìîæíî ñäåëàòü gated.
Îòâåòèòü ñ öèòèðîâàíèåì
  #32  
Ñòàðûé 09.10.2007, 17:32
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
Ïî÷åìó. Åe æå òîæå ìîæíî ñäåëàòü gated.
Êîíå÷íî, ìîæíî, íî ñóùåñòâóåò åùå ñòàòèñòèêà (ÿ èìåþ â âèäó òó, ÷òî ñâÿçàíà ñ ââîäèìîé àêòèâíîñòüþ è êà÷åñòâîì èçîáðàæåíèÿ), à òàêæå âðåìåíåì èññëåäîâàíèÿ. Âñå ýòî â íàøèõ óñëîâèÿõ âàæíî. Áîëåå òîãî, åñëè Âû ñîáèðàåòå ìåíåå 16 êàäðîâ íà öèêë, òî êà÷åñòâî îöåíêè ôóíêöèè ðåçêî ïàäàåò. Ïðè èññëåäîâàíèè ñ Tl èç-çà íèçêîé äîçû îáû÷íî ïèøóò òîëüêî 8 êàäðîâ è èíôîðìàöèÿ î äâèæåíèè è ñèñòîëè÷åñêîì óòîëùåíèè ïîëó÷àåòñÿ äîñòàòî÷íî ãðóáîé. Äèàñòîëè÷åñêóþ ôóíêöèþ ïî ïîëó÷àåìîé êðèâîé âîîáùå ÷èòàòü íå ïðåäñòàâëÿåòñÿ âîçìîæíûì. Äà è îáúåìíûå ïàðàìåòðû ïðè òàêîì âàðèàíòå ñáîðà çíà÷èìî èçìåíÿþòñÿ.

Âû æå ãîâîðèëè îá îòëîæåííûõ èçîáðàæåíèÿõ. Âîò ÿ ñ òîé ìåòîäèêîé è ñðàâíèë.
Îòâåòèòü ñ öèòèðîâàíèåì
  #33  
Ñòàðûé 09.10.2007, 18:08
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ÎÊ. Âîçìîæíî. Ýòî âñå ñëèøêîì îòëè÷àåòñÿ îò òîãî, ÷òî äåëàþò ó íàñ. Íàäî ðàçáèðàòüñÿ.
À ïî÷åìó âû íå äåëàåòå íàãðóçêó?
Îòâåòèòü ñ öèòèðîâàíèåì
  #34  
Ñòàðûé 09.10.2007, 18:21
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
ÎÊ. Âîçìîæíî. Ýòî âñå ñëèøêîì îòëè÷àåòñÿ îò òîãî, ÷òî äåëàþò ó íàñ. Íàäî ðàçáèðàòüñÿ.
À ïî÷åìó âû íå äåëàåòå íàãðóçêó?
À ó Âàñ âî âñåõ êëèíèêàõ âñå îäèíàêîâî äåëàþò? ×òî-òî ïî ëèòåðàòóðå ÿ ýòîãî íå çàìåòèë. Íàãðóçêó ÿ äåëàþ. Ïðîñòî â ýòîì ñëó÷àå íå áûëî òàêîé íåîáõîäèìîñòè. ß áû ñäåëàë åé ñ íèòðîãëèöåðèíîì èññëåäîâàíèå, íî ïîáîÿëñÿ è åå ñóáúåêòèâíîãî îòíîøåíèÿ è íèçêîãî àðòåðèàëüíîãî äàâëåíèÿ 85/60-55.
Îòâåòèòü ñ öèòèðîâàíèåì
  #35  
Ñòàðûé 09.10.2007, 18:40
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íå âî âñåõ. Åñòü âàðèàíòû íàãðóçî÷íûõ òåñòîâ:
Same day Rest and Stress study.
Two-day Stress/Rest Protocol
Dual Isotope Scanning

Äëÿ îïðåäåëåíèÿ æèçíåñïîñîáíîñòè:
Thallium stress redistribution re-injection technique
Thallium rest redistribution technique

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Îòâåòèòü ñ öèòèðîâàíèåì
  #36  
Ñòàðûé 09.10.2007, 18:46
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
Íå âî âñåõ. Åñòü âàðèàíòû íàãðóçî÷íûõ òåñòîâ:
Same day Rest and Stress study.
Two-day Stress/Rest Protocol
Dual Isotope Scanning

Äëÿ îïðåäåëåíèÿ æèçíåñïîñîáíîñòè:
Thallium stress redistribution re-injection technique
Thallium rest redistribution technique

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Çàìå÷àòåëüíî! À gated SPECT ñ ïðåïàðàòàìè, ìå÷åííûìè òåõíåöèåì 99ì ó Âàñ íèêòî íå ðàáîòàåò?
Îòâåòèòü ñ öèòèðîâàíèåì
  #37  
Ñòàðûé 09.10.2007, 18:48
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ïðîñòèòå, íå ïîíÿëà âîïðîñ.

Same day Rest and Stress study - Tc-99m sestamibi, (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin).
Two-day Stress/Rest Protocol - Tc-99m sestamibi (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin).
Dual Isotope Scanning - Tc-99m sestamibi (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin) ïëþñ T1-201 chloride.

Åñòåñòâåííî gated.

Êîììåíòàðèè ê ñîîáùåíèþ:
FRSM îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #38  
Ñòàðûé 09.10.2007, 19:06
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
Ïðîñòèòå, íå ïîíÿëà âîïðîñ.

Same day Rest and Stress study - Tc-99m sestamibi, (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin).
Two-day Stress/Rest Protocol - Tc-99m sestamibi (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin).
Dual Isotope Scanning - Tc-99m sestamibi (èëè Tc-99m teboroxime, èëè Tc-99m tetrofosmin) ïëþñ T1-201 chloride.

Åñòåñòâåííî gated.
Ýòî ÿ íå ïîíÿë, ïðîñòèòå. Íó âîò, âèäèòå è ó Âàñ ñ gated SPECT ðàáîòàþò. È ãäå òîëüêî íå ðàáîòàþò.. è ñ ÷åì òîëüêî íå ñðàâíèâàþò..[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ] è ìîæíî ïðîäîëæàòü åùå äîëãî è ïî ðàçíûì ïîâîäàì...
Îòâåòèòü ñ öèòèðîâàíèåì
  #39  
Ñòàðûé 09.10.2007, 19:26
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ðàáîòàþò. Íî â âèäå stress/rest.
È æèçíåñïîñîáíîñòü ìèîêàðäà ïî-äðóãîìó îïðåäåëÿþò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #40  
Ñòàðûé 09.10.2007, 19:47
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
Ðàáîòàþò. Íî â âèäå stress/rest.
È æèçíåñïîñîáíîñòü ìèîêàðäà ïî-äðóãîìó îïðåäåëÿþò.
 èäåàëå ýòî òàê, íî ìîëîäîé æåíùèíå, êîðîíàðîãðàôèþ è ÝÊà êîòîðîé Âû âèäåëè, òîëåðàíòíîñòü êîòîðîé ê ôèçè÷åñêîé íàãðóçêå êîòîðîé áûëà íèçêîé ÿ ñêîðåå áû âûïîëíèë ýòîò ìåòîä ïðè ïðèåìå íèòðîãëèöåðèíà. Íî è ýòî áûëî íå ïðîñòî.
 ýòîì ñëó÷àå ÿ âûáðàë âàðèàíò ñõîæèé ñ ýòèì
J Thorac Cardiovasc Surg 2003;126:1328-1334Quantitative gated myocardial perfusion single photon emission computed tomography improves the prediction of regional functional recovery in akinetic areas after coronary bypass surgery: useful tool for evaluation of myocardial viability Toshifumi Murashita, MD, PhDa,*, Yutaka Makino, MDa, Yasuhiro Kamikubo, MD, PhDa, Keishu Yasuda, MD, PhDa, Megumi Mabuchi, MD, PhDb, Nagara Tamaki, MD, PhDb OBJECTIVE: Assessment of myocardial viability in akinetic areas is essential in surgery for ischemic heart disease, including coronary artery bypass grafting and left ventriculoplasty. The aim of this study is to evaluate the utility of quantitative indices of perfusion uptake, wall motion, and wall thickening of each region calculated by quantitative electrocardiogram-gated single photon emission computed tomography (SPECT) for prediction of functional recovery after coronary artery bypass grafting.

METHODS: Forty patients scheduled for coronary artery bypass grafting were prospectively included. Electrocardiogram-gated SPECT was performed before and 1 week and 3 months after operation, and coronary angiography was performed before and after operation. The myocardium was divided into 9 segments and myocardial viability, assessed by improvement of the wall motion score using a cine mode display, and evaluated by radionuclide criteria (perfusion uptake, wall motion, wall thickening). Twenty-four segments with moderate hypokinesis and 14 segments with akinesis with patent grafts were assessed.
RESULTS: All segments with moderate hypokinesis except 1 (96%) had improved wall motion scores postoperatively, whereas of 14 segments with akinesis only 7 segments (50%) had improved wall motion scores. The preoperative perfusion uptake in the improved segments was significantly higher than in the nonimproved segments (62.7% ± 15.6% vs 46.4% ± 24.5%, P = .01). There was a significant difference in wall motion between the improved and nonimproved segments (3.8 ± 2.2 mm vs 1.4 ± 1.4 mm, P = .001), and the preoperative wall thickening of the improved segments was significantly higher than in the nonimproved segments (27.2% ± 14.1% vs 8.2% ± 10.3%, P < .0001). The optimal cutoff level of perfusion uptake was 50%, with the highest accuracy of 72%, and the optimal cutoff levels of wall thickening and wall motion were 10% and 1.5 mm, with the highest accuracies of 76% and 85%, respectively.
CONCLUSION: The regional functional index calculated by electrocardiogram-gated SPECT indicated that wall thickening was well correlated with functional recovery compared with wall motion or perfusion uptake. This suggests that the wall thickening calculated by electrocardiogram-gated SPECT may be more useful to predict functional recovery than regional myocardial perfusion. Or, it could suggest that in addition to perfusion uptake, wall thickening could enhance the objective assessment of myocardial viability.
È òàêèå èñòî÷íèêè, êîãäà âûïîëíÿåòñÿ è èíòåðïðåòèðóåòñÿ gated SPECT òîëüêî â ïîêîå ìîæíî íàéòè åùå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #41  
Ñòàðûé 09.10.2007, 19:48
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À ïî÷åìó âû íå õîòåëè ñäåëàòü Pharmacologic stress?[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Âîò, íàâåðíîå, äëÿ êàðäèîëîãîâ ìîæåò áûòü èíòåðåñíà ãëàâà èç ó÷åáíèêà ïðî Nuclear Cardiac Imaging:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

SPECT â ïîêîå, ìíå êàæåòñÿ, ïîêà íå ÿâëÿåòñÿ ñòàíäàðòîì äiàãíîñòèêè.
Îòâåòèòü ñ öèòèðîâàíèåì
  #42  
Ñòàðûé 09.10.2007, 19:54
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
À ïî÷åìó âû íå õîòåëè ñäåëàòü Pharmacologic stress?[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Âîò, íàâåðíîå, äëÿ êàðäèîëîãîâ ìîæåò áûòü èíòåðåñíà ãëàâà èç ó÷åáíèêà ïðî Nuclear Cardiac Imaging:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
SPECT â ïîêîå, ìíå êàæåòñÿ, ïîêà íå ÿâëÿåòñÿ ñòàíäàðòîì äiàãíîñòèêè.
Íå õîòåë, à íå ìîã!
À äëÿ íàøèõ êàðäèîëîãîâ, áîþñü, êíèãè ïðî Nuclear Cardiac Imaging íå áóäóò èíòåðåñíû... Ïîòîìó, ÷òî ýòîé ñàìîé ßäåðíîé Êàðäèîëîãèè ó íà ñåé÷àñ íåò! È Âûñøèå êàðäèîëîãè÷åñêèå àâòîðèòåòû îòêðûòî çàÿâëÿþò, ÷òî íàì îíà è íå íóæíà... Äîðîãàÿ yananshs! Çäåñü óñòàâîì íå ïîëîæåíî ãîâîðèüü îá ýòîì. Õîòèòå - íà Ñîëâåé ÿ âàì íà ýòè âîïðîñû ïîäðîáíî îòâå÷ó..
Îòâåòèòü ñ öèòèðîâàíèåì
  #43  
Ñòàðûé 09.10.2007, 19:54
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Èçâèíèòå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #44  
Ñòàðûé 09.10.2007, 22:15
Àâàòàð äëÿ ostroumov
ostroumov ostroumov âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 26.04.2006
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 407
Ñêàçàë(à) ñïàñèáî: 9
Ïîáëàãîäàðèëè 29 ðàç(à) çà 28 ñîîáùåíèé
ostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåostroumov ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Öèòàòà:
Ñîîáùåíèå îò yananshs Ïîñìîòðåòü ñîîáùåíèå
À ïî÷åìó âû íå õîòåëè ñäåëàòü Pharmacologic stress?[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

Âîò, íàâåðíîå, äëÿ êàðäèîëîãîâ ìîæåò áûòü èíòåðåñíà ãëàâà èç ó÷åáíèêà ïðî Nuclear Cardiac Imaging:
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

SPECT â ïîêîå, ìíå êàæåòñÿ, ïîêà íå ÿâëÿåòñÿ ñòàíäàðòîì äiàãíîñòèêè.
Èíòåðåñíî, ÷åì âûçâàíî ýòî ìíå êàæåòñÿ? Çíàíèåì ãàéäîâ, èëè çíàíèåì âîçìîæíîñòåé è îãðàíè÷åíèé ñàìîãî ìåòîäà?
Îòâåòèòü ñ öèòèðîâàíèåì
  #45  
Ñòàðûé 10.10.2007, 00:25
Àâàòàð äëÿ yananshs
yananshs yananshs âíå ôîðóìà Ïîë æåíñêèé
çàáàíåí
      
 
Ðåãèñòðàöèÿ: 25.02.2003
Ãîðîä: NY
Ñîîáùåíèé: 9,664
Ñêàçàë(à) ñïàñèáî: 15
Ïîáëàãîäàðèëè 56 ðàç(à) çà 51 ñîîáùåíèé
yananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåyananshs ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íèêîãäà íåëüçÿ áûòü óâåðåííûì, ÷òî ÷òî-òî íå èçìåíèëîñü 2 ìèíóòû íàçàä.
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 13:46.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.